Feasibility trial of a scalable transdiagnostic group psychological intervention for Syrians residing in a refugee camp

Open Access
Authors
  • A. Akhtar
  • L. Giardinelli
  • A. Bawaneh
  • M. Awwad
  • H. Al-Hayek
  • C. Whitney
  • M.J.D. Jordans
  • M. Sijbrandij
  • P. Cuijpers
  • K. Dawson
  • R. Bryant
Publication date 2021
Journal European Journal of Psychotraumatology
Article number 1932295
Volume | Issue number 12 | 1
Number of pages 13
Organisations
  • Faculty of Social and Behavioural Sciences (FMG) - Amsterdam Institute for Social Science Research (AISSR)
Abstract
Background
Approximately 10% of Syrian refugees currently reside in camp settings, which can impose additional post-migration stressors. With elevated rates of psychological distress and few available resources, task-shifting psychosocial programmes are necessary to provide adequate care. One such programme developed by the World Health Organization (WHO) is Group Problem Management Plus (GroupPM+).

Objective
This study aimed to test the safety and acceptability of GroupPM+ in a refugee camp and to identify areas for adaptation in preparation for a definitive RCT.

Method
A feasibility randomized controlled trial (RCT) was conducted in Azraq refugee camp in Jordan. Inclusion criteria were: (1) Syrian adults aged ≥18 years, (2) parent of a child aged 10–16 years, (3) experiencing psychological distress as defined by a score of ≥16 on the Kessler Distress Scale, and (4) ≥17 on the WHO Disability Assessment Schedule 2.0. Following baseline assessments, participants were randomized to receive GroupPM+ or enhanced treatment-as-usual. Post-assessments were conducted one week following the last GroupPM+ session. Primary outcomes were feasibility and acceptance of GroupPM+; symptoms of anxiety, depression, PTSD, prodromal psychosis, grief, and child’s self-reported psychological distress were also assessed.

Results
Of the 207 persons screened, 64 (31%) screened positive for psychological distress. Of the 35 randomized into the GroupPM+ intervention, 24 (69%) completed the intervention. No adverse events were reported throughout the trial. Children whose parents received GroupPM+ had greater reductions in internalizing and externalizing symptoms at posttreatment. 55 (86%) participants completed the post-assessment follow-up. These results demonstrate both the feasibility of conducting the trial in a camp and acceptance of the GroupPM+ intervention by Syrian refugees.

Conclusions
Following the feasibility trial, both the implementation procedures and intervention were safe and culturally acceptable. The results support the readiness for a definitive RCT to determine the effectiveness and cost-effectiveness of the intervention in camp settings.
Document type Article
Language English
Published at https://doi.org/10.1080/20008198.2021.1932295
Downloads
20008198.2021 (Final published version)
Permalink to this page
Back